Rainmed Medical Limited (HKG:2297)
Hong Kong · Delayed Price · Currency is HKD 0.2260
+0.0030 (1.35%)
Jun 1, 2026, 4:08 PM HKT
Rainmed Medical Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -77.08 | -113.5 | -115.83 | -1,346 | -633.65 |
Depreciation & Amortization | 10.01 | 22.54 | 22.24 | 16.39 | 10.81 |
Other Amortization | 10.44 | - | - | 0.28 | 0.05 |
Loss (Gain) From Sale of Assets | 0.27 | 0.01 | 0.01 | 0.02 | 0.04 |
Asset Writedown & Restructuring Costs | 6.81 | 18.76 | - | - | - |
Loss (Gain) From Sale of Investments | -2.48 | -1.25 | -1.06 | -0 | -0.04 |
Stock-Based Compensation | -1 | 0.88 | 7.48 | 13.4 | 67.17 |
Other Operating Activities | -1.7 | -2.78 | -9.32 | 1,204 | 492.69 |
Change in Accounts Receivable | -21.65 | -6.12 | -5.41 | -2.07 | -0.43 |
Change in Inventory | -0.31 | -1.26 | -0.74 | 2.3 | -4.6 |
Change in Accounts Payable | -5.16 | -14.92 | -22.94 | 9.42 | 16.29 |
Change in Unearned Revenue | 3.22 | 2.37 | 0.24 | -3.24 | -16.24 |
Change in Other Net Operating Assets | 0.53 | 10.97 | 1.04 | -5.74 | -4.95 |
Operating Cash Flow | -78.11 | -84.31 | -124.29 | -111.22 | -72.83 |
Capital Expenditures | -3.38 | -44.2 | -84.68 | -17.11 | -30.84 |
Sale of Property, Plant & Equipment | 0.15 | 0.1 | 0.07 | 0.16 | 0.09 |
Cash Acquisitions | - | - | -13.89 | - | - |
Sale (Purchase) of Intangibles | - | -9.6 | -26.3 | -12.71 | -0.28 |
Investment in Securities | 10.66 | 58.59 | 291.43 | -482.25 | 3.04 |
Other Investing Activities | 0.31 | 1.42 | 9.66 | 0.17 | - |
Investing Cash Flow | 7.74 | 6.31 | 180.29 | -515.74 | -27.98 |
Long-Term Debt Issued | 38.6 | 20.8 | 30.57 | 18 | 270.41 |
Long-Term Debt Repaid | -40.16 | -19.31 | -45.51 | -6.6 | -284.88 |
Net Debt Issued (Repaid) | -1.56 | 1.49 | -14.94 | 11.4 | -14.47 |
Issuance of Common Stock | 32.51 | - | - | 126.99 | 0.93 |
Other Financing Activities | -0.63 | -0.77 | -0.94 | -17.66 | -9.84 |
Financing Cash Flow | 30.32 | 0.72 | -15.88 | 120.73 | 633.85 |
Foreign Exchange Rate Adjustments | -0.15 | -2.21 | 2.84 | 38.21 | -1.48 |
Net Cash Flow | -40.2 | -79.48 | 42.97 | -468.02 | 531.55 |
Free Cash Flow | -81.49 | -128.5 | -208.97 | -128.33 | -103.67 |
Free Cash Flow Margin | -424.94% | -322.68% | -285.40% | -153.50% | -127.67% |
Free Cash Flow Per Share | -0.06 | -0.11 | -0.18 | -0.14 | -0.16 |
Cash Interest Paid | 0.63 | 0.77 | 0.94 | 0.14 | 3.17 |
Cash Income Tax Paid | 0.03 | 0.26 | 0 | - | - |
Levered Free Cash Flow | 82.52 | -97.67 | -183.52 | -92.47 | - |
Unlevered Free Cash Flow | 82.97 | -97.08 | -182.71 | -92 | - |
Change in Working Capital | -23.37 | -8.96 | -27.8 | 0.68 | -9.92 |